« Previous
Next »
Journal of Hepatology
Volume 49, Issue 5
, Pages
688-694
, November 2008
The HEP-NET B/C co-infection trial: A prospective multicenter study to investigate the efficacy of pegylated interferon-α2b and ribavirin in patients with HBV/HCV co-infection
To access this article, please choose from the options below
☆ A.P., H.W., W.B., T.B., S.Z., U.S., K.D., M.P.M., C.T. were investigators in several clinical trials using different interferons. They also have received research grants and lecturer fees by Schering-Plough. M.P.M. and S.Z. have served as advisory board members for Schering-Plough. W.B. is currently an employee of Boehringer Ingelheim, Germany.
PII: S0168-8278(08)00282-1
doi: 10.1016/j.jhep.2008.03.028
« Previous
Next »
Journal of Hepatology
Volume 49, Issue 5
, Pages
688-694
, November 2008
